Skip to main content
. 2024 Dec 23;15:1522761. doi: 10.3389/fimmu.2024.1522761

Table 1.

Characteristics of the study population.

Characteristics Group P-value
LUAD Control
Age, median (IQR) 57.5(23) 58(30) 0.933
Male/female (%) 105/95(52.5%/47.5%) 237/163(59.3%/40.8%) 0.137
Smoking 89/44.5%) 180(45%) 0.931
Drinking (%) 35(17.5%) 98(24.5%) 0.06
Hypertension (%) 63(31.5%) 124(31%) 0.926
Diabetes (%) 24(12%) 38(9.5%) 0.393
Fatty liver (%) 51(25.5%) 95(23.8%) 0.687
TC (mmol/L) 1.68(1.77) 2.67(3.5) <0.001
TG (mmol/L) 2.14(0.96) 1.86(0.93) 0.024
LDL (mmol/L) 2.84(1.19) 2.93(1.11) 0.030
HDL (mmol/L) 1.71(0.75) 2.33(2.89) <0.001
APOA1 (mmol/L) 1.25(0.92) 1.73(0.69) <0.001
APOB (mmol/L) 1.25(0.92) 1.93(0.4) <0.001
Lp(a)(mmol/L) 177(113.3) 402.5(206) <0.001
FFA (mmol/L) 0.35(0.39) 0.52(0.39) <0.001

IQR, Interquartile Range; LUAD, lung adenocarcinoma; TC, Total Cholesterol; TG, Triglycerides; LDL, Low-Density Lipoprotein; HDL, High-Density Lipoprotein; APOA1, Apolipoprotein A1; APOB, Apolipoprotein B; Lp(a), Lipoprotein (a); FFA, Free Fatty Acids.

Bold P-values indicate statistically significant differences (P < 0.05).